GMAB Competitors & Alternatives
Compare Genmab AS with similar stocks in the same industry
Biotechnology
GMAB
Main Stock$34.75
Tradestie Score
47
Market Cap
$19.56B
P/E Ratio
27.2
Revenue Growth
0.2%
Analyst Upside
+12.4%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
INSM
Insmed, Inc.
|
$111.12
|
$31.13B | - | 49 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$96.90
|
$24.57B | - | 55 | Compare |
|
INCY
Incyte Genomics Inc
|
$115.30
|
$16.93B | 15.5 | 56 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$57.16
|
$15.70B | 31.3 | 70 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$16.76
|
$15.22B | - | 49 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$227.87
|
$12.36B | 17.9 | 66 | Compare |
|
EXEL
Exelixis Inc
|
$58.39
|
$11.09B | 18.2 | 43 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$35.72
|
$10.76B | - | 50 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$190.01
|
$10.74B | - | 35 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$57.18
|
$10.53B | 157.9 | 46 | Compare |
More GMAB Analysis
Data updated: Oct 04, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry